Patent portfolios: maximise the value and minimise the cost

According to patent information company IFI Claims, 66% of what it said were the most prolific patenting companies also feature in the Financial Times’stop 500—compelling evidence that research and development (R&D) today creates tomorrow’s successes.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Chinese medtech company fined by UPC over injunction breaches

21 May 2026 The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.

Europe

Orrick lands five-member M&A team in Paris

18 May 2026 A high-profile Paris-based partner and four others join the firm, bringing experience across M&A, venture capital and life sciences-focused transactions.

Europe

IP in the deal room: The risks that bite before, during and after closing

7 May 2026 Experts from Johnson & Johnson and Novartis took the stage at INTA to share the pitfalls lurking inside mergers, acquisitions and spin-offs and what in-house counsel can do about them.

More features

Chinese medtech company fined by UPC over injunction breaches

Kirkland & Ellis subject of alleged conflict in trade secrets clash

Orrick lands five-member M&A team in Paris

IP in the deal room: The risks that bite before, during and after closing

Five generations at work: How teams are bridging the gap

WATCH: John Ward, trademarks VP and associate GC of Moderna, at INTA

Brussels under scrutiny for IP policy as US flags risks to innovation

Squire Patton Boggs promotes partner to head Europe IP&T practice

Patent portfolios: maximise the value and minimise the cost

More on this story

Editor's picks

Editor's picks

More features